Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting Septembe...(2 4153 Other investments ...),Health

Other investments 16,588 21,741

Intangible assets, net 47,880 36,235

Goodwill 63,729 58,729

Deferred charges and other assets 16,000 8,828

Non-current deferred income taxes, net 49,545 50,917

Total assets $810,418 $736,030

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Short-term and current portion of

long-term debt $204,469* $3,011

Accounts payable 48,297 56,412

Payables due to distribution agreement

partners 89,585 46,937

Accrued salaries and employee benefits 15,510 12,780

Accrued expenses and other current

liabilities 14,574 25,739

Income taxes payable 16,974 9,683

Liabilities held for sale - 1,944

Total current liabilities 389,409 156,506

Long-term debt, less current portion - 202,001

Other long-term liabilities - 335

Stockholders' equity:

Preferred Stock, par value $.0001 per

share, authorized 6,000,000 shares;

none issued and outstanding - -

Common Stock, par value $.01 per share,

authorized 90,000,000 shares, issued

and outstanding 35,901,276 and

35,114,026 shares 359 351

Additional paid-in-capital 254,013 217,403

Retained earnings
'/>"/>